Table 2.
Prevalence of COVID-19 based on the type of drug.
| Type of Drug | Condition | Coronavirus | Total | OR (95%CI) | P Value | |
|---|---|---|---|---|---|---|
| positive | negative | |||||
| HCQ | yes | 30(50.0%) | 280(41.1%) | 310(41.8%) | 1.436(0.846–2.436) | 0.178 |
| no | 30(50.0%) | 402(58.9%) | 432(58.2%) | |||
| MTX | yes | 26(43.3%) | 271(39.7%) | 297(40.0%) | 1.163(0.682–1.981) | 0.597 |
| no | 34(56.7%) | 412(60.3%) | 446(60.0%) | |||
| SSZ | yes | 15(25.0%) | 173(25.4%) | 188(25.4%) | 0.979(0.532–1.800) | 0.945 |
| no | 45(75.0%) | 508(74.6%) | 553(74.6%) | |||
| Prednisolone | Upper 15mg | 17(28.3%) | 120(17.6%) | 137(18.5%) | 0.046 | |
| Under 15mg | 38(63.3%) | 444(65.1%) | 482(65.0%) | |||
| no use | 5(8.3%) | 118(17.3%) | 123(16.6%) | |||
| Rituximab | yes | 5(8.3%) | 20(2.9%) | 25(3.4%) | 3.009(1.087–8.327) | 0.026 |
| no | 55(91.7%) | 662(97.1%) | 717(96.6%) | |||
| Altebrel (Etanercept) | yes | 1(1.7%) | 23(3.4%) | 24(3.2%) | 0.486(0.064–3.660) | 0.474 |
| no | 59(98.3%) | 659(96.6%) | 718(96.8%) | |||
| Cyclophosphamide | yes | 2(3.3%) | 26(3.8%) | 28(3.8%) | 0.870(0.201–3.758) | 0.825 |
| no | 58(96.7%) | 656(96.2%) | 714(96.2%) | |||
| Azaram | yes | 4(6.7%) | 65(9.5%) | 69(9.3%) | 0.678(0.238–1.930) | 0.464 |
| no | 56(93.3%) | 617(90.5%) | 673(90.7%) | |||
OR: Odds ratio; CI: Confidence interval; HCQ: Hydroxychloroquine; MTX: Methotrexate; SSZ: Sulfasalazine.